Cancer treatment in pulmonary hypertension: cause or cure?

H.J. Bogaard (Amsterdam, Netherlands)

Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H.J. Bogaard (Amsterdam, Netherlands). Cancer treatment in pulmonary hypertension: cause or cure?. Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018


Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019


Interventional treatment of pulmonary hypertension: where are we now?
Source: Virtual Congress 2020 – Breathing disorders and cardiovascular diseases
Year: 2020


Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005

Chronic thromboembolic pulmonary hypertension: do we need a new definition?
Source: Eur Respir J 2014; 44: 1401-1403
Year: 2014


Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019



Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy?
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016


Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
Source: Eur Respir Rev 2009; 18: 24-28
Year: 2009


Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015



Chronic thromboembolic pulmonary hypertension and splenectomy: Is there a link?
Source: Eur Respir J 2003; 22: Suppl. 45, 218s
Year: 2003

Diabetes mellitus as cause of treatment failure and relapses of pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 311s
Year: 2001

Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015

Pulmonary hypertension in the elderly: a different disease?
Source: Breathe 2016; 12: 43-49
Year: 2016


PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Severe pulmonary hypertension in lung disease: phenotypes and response to treatment
Source: Eur Respir J 2015; 46: 1378-1389
Year: 2015



Surgical treatment of chronic thromboembolic pulmonary hypertension: a single centre experience
Source: Eur Respir J 2001; 18: Suppl. 33, 14s
Year: 2001